Psychemedics Corp PMD:NASDAQ

RT Quote | NASDAQ | USD

Last | 02/26/21 EST

7.00

-0.08 (-1.13%)

Volume

18,028

52 week range

3.58 - 8.98

...

Loading . . .

KEY STATS

Open7.01
Day High7.11
Day Low6.90
Prev Close7.08
52 Week High8.98
52 Week High Date02/26/20
52 Week Low3.58
52 Week Low Date10/29/20
Market Cap38.71M
Shares Out5.53M
10 Day Average Volume0.03M
Dividend0.00
Dividend Yield-
Beta0.85
1 Year % Change-20

RATIOS/PROFITABILITY

EPS (TTM)-0.70
P/E (TTM)-10.05
Fwd P/E (NTM)7.69
EBITDA (MRQ)-2.873M
ROE (MRQ)-24.84%
Revenue (MRQ)24.74M
Gross Margin (MRQ)28.67%
Net Margin (MRQ)-15.55%
Debt To Equity (MRQ)33.24%

EVENTS

Earnings Date-
Ex Div Date02/20/2020
Div Amount0.18
Split Date-
Split Factor-

Latest Psychemedics Corp News

There is no recent news for this security.

Latest PMD News From Our Partners

January 30, 2021

Psychemedics Corp.: Trucking Along Into A Potential Big Catalyst ($21 PT) Seeking Alpha

QUOTE FINDER

Market Movers

Profile

Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for...

Raymond Kubacki Jr.

Chairman

Charles Doucot

Executive Vice President

Andrew Limbek CPA

Vice President

Address

125 Nagog Park Ste 200

Acton, MA

01720-3451

United States

https://www.psychemedics.com/